Re: Assel et al.: Genetic polymorphisms of CFH and ARMS2 do not predict response to antioxidants and zinc in patients with age-related macular degeneration (Ophthalmology. 2018;125:391-397)

We requested that the National Institutes of Health Agency of Intramural Research Integrity investigate the use of the National Eye Institute's position of authority to advance its commercial interest in the Age-Related Eye Disease Study (AREDS) formulation. A statistical review was commissioned and is reported, in part, in the publication by Assel et  al.1 As part of the review process genotypes from 535 AREDS cases that were not analyzed in the publications that first highlighted potential genotype-specific harm and previously unavailable were provided.
Source: Ophthalmology - Category: Opthalmology Authors: Tags: Correspondence Source Type: research